It can be difficult to determine the type of dementia. To determine the cause of dementia, the doctor must recognise the pattern of skill and function loss and determine what a person is still capable of doing. Biomarkers have recently become available to aid in the diagnosis of Alzheimer's disease.
Changes in the cholinergic system in Alzheimer's disease have been known for more than 25 years. A variety of therapeutic approaches have been developed to stimulate the Dementia Drugs, but ChEIs are the only compounds that have consistently demonstrated efficacy in clinical trials. ChEIs inhibit acetylcholine hydrolysis at the synapse, increasing its availability to muscarinic and nicotinic receptors.
Read More @ https://expressmyblog.blogspot.com/2023/03/the-use-of-receptor-antagonists-in.html
Facebook Conversations